FDA-Drug2023-09-13Class III
Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
Esperion
Hazard
Failed dissolution specifications: below specification results at stability 12-month
Sold states
Nationwide USA
Affected count
45,240 bottles
Manufactured in
3891 Ranchero Dr Ste 150, N/A, Ann Arbor, MI, United States
Products
Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1143-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief